Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout

Fig. 1

Typical 500-MHz Carr–Purcell–Meiboom–Gill (CPMG) 1H nuclear magnetic resonance spectra of human serum samples from controls (a), patients with hyperuricemia (b) and patients with gout (c). The dotted regions were vertically expanded 32 times. 1, high-density lipoprotien; 2, very low-density lipoprotein; 3, isoleucine; 4, leucine; 5, valine; 6, ethanol; 7, 3-hydroxybutytrate; 8, lipid; 9, lactate; 10, alanine; 11, lysine; 12, acetate; 13, glutamine; 14, methionine; 15, glycoprotein; 16, acetone; 17, glutamate; 18, citrate; 19, aspartate; 20, methylguanidine; 21, trimethylamine; 22, dimethylglycine; 23, creatine; 24, creatinine; 25, choline; 26, arginine; 27, β-glucose; 28, trimethylamine n-oxide; 29, myo-inositol; 30, proline; 31, scyllo-inositol; 32, α-glucose; 33, glycine; 34, threonine; 35, triglycerides; 36, unsaturated lipids; 37, tyrosine; 38, 1-methylhistidine; 39, phenylalanine; 40, tryptophan; 41, formate

Back to article page
\